Yes, Botox Really Can Treat Headaches — But There's an Important Catch
“Botox can treat headaches”
The argument in brief
You may have heard that Botox, the cosmetic wrinkle treatment, can also treat headaches. This is true — but only for a specific condition called chronic migraine. The FDA approved Botox for this use in 2010, backed by large clinical trials showing it cuts headache days by roughly half in many patients.
Data: PREEMPT 1 & 2 pooled analysis, Cephalalgia 2010
Why it spread
Botox is so strongly associated with cosmetic procedures that its use as a serious medical treatment feels surprising and counterintuitive — exactly the kind of story people share. At the same time, chronic migraine is a debilitating condition with few good options, so patients and their families are highly motivated to seek out and spread information about anything that might help.
The claim that Botox can treat headaches is true, but it comes with a crucial detail that often gets lost: Botox is approved specifically for chronic migraine, defined as 15 or more headache days per month. It is not a general cure for any headache you might get after a stressful day.
The FDA approved onabotulinumtoxinA — the medical name for Botox — in October 2010 for exactly this purpose. That approval was built on solid evidence. The PREEMPT clinical trial program, published in the journal Cephalalgia in 2010, ran two large randomized controlled trials and found that Botox significantly reduced the number of headache days per month compared to a placebo. Patients receiving Botox saw a mean reduction of about 8.4 headache days per month, versus 6.6 for placebo — a meaningful difference for people whose lives are dominated by near-daily pain.
The American Migraine Foundation reports that roughly half of chronic migraine patients who try Botox see their headache days cut by about 50%. It is given as a series of small injections around the head and neck every 12 weeks by a trained healthcare provider. A 2021 Cochrane Review — one of the most rigorous types of evidence summaries in medicine — confirmed moderate-quality evidence supporting its use as a preventive treatment.
Regulators outside the US agree. The UK's National Institute for Health and Care Excellence, known as NICE, recommends Botox for chronic migraine patients who have already tried and failed at least three other preventive treatments. This is not a fringe or experimental therapy — it sits firmly within mainstream medicine.
The honest caveat is that Botox does not work for everyone, and it is not approved for episodic migraines or ordinary tension headaches. If you see headlines saying Botox cures headaches without that context, the story is incomplete. Anyone considering it should talk to a neurologist or headache specialist, not a cosmetic clinic.
This claim spread partly because the idea of a wrinkle treatment doubling as a migraine therapy sounds almost too strange to be true — which makes it highly shareable. Chronic migraine sufferers, who are often desperate for relief, also actively circulate treatment information online, which amplified awareness of this legitimate but widely misunderstood use.
Sources
- FDA Drug Approval Database
The FDA approved onabotulinumtoxinA (Botox) in October 2010 specifically for the prevention of chronic migraine in adults, defined as headaches occurring 15 or more days per month.
- PREEMPT Clinical Trial Program (Cephalalgia, 2010)
Two Phase 3 randomized controlled trials (PREEMPT 1 and 2) demonstrated that onabotulinumtoxinA significantly reduced headache days per month compared to placebo in chronic migraine patients.
- American Migraine Foundation
Botox injections every 12 weeks have been shown to reduce the number of headache days by approximately 50% in roughly half of chronic migraine patients who receive the treatment.
- National Institute for Health and Care Excellence (NICE)
NICE recommends Botox (onabotulinumtoxinA) as a treatment option for the prophylaxis of headaches in adults with chronic migraine who have not responded to at least three prior preventive treatments.
- Cochrane Review – Botulinum toxins for the prevention of migraine in adults (2021)
The Cochrane review found moderate-quality evidence that botulinum toxin type A reduces frequency of chronic migraine episodes compared to placebo, supporting its use as a preventive treatment.
Related debunks
- UnverifiableCan't Confirm or Deny: Bill Ritter's Claim About His Cancer Treatment Is Unverifiable — Not False
- UnverifiableNo Evidence Bill Ritter Has Been Diagnosed With Alzheimer's — The Claim Is Unverified
- UnverifiableYes, Whey, Soy, and Pea Proteins Really Can Leave a Bad Aftertaste — And Science Explains Why